Stockreport

Bausch + Lomb Spotlights BL 1107 Eye Drop and ELIOS Implant-Free Laser as Glaucoma Catalysts [Yahoo! Finance]

Bausch + Lomb Corporation Common Shares  (BLCO) 
PDF Bausch + Lomb (NYSE:BLCO) highlighted two glaucoma programs during a Wells Fargo-hosted “2026 MedTech Innovation Spotlight” call, focusing on BL 1107, a next-generation [Read more]